Alam Mohammad Mumtaz, Sarkar Deba Priya, Alam Ozair, Husain Asif, Marella Akranth, Akhtar Mymoona, Shaquiquzzaman Mohammad, Khanna Suruchi
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Jamia Hamdard, New Delhi-110062, India.
Acta Pol Pharm. 2011 Mar-Apr;68(2):231-6.
A series of substituted 3-[(substituted-2-chloroquinolin-3-yl)methylene]-5-(substituted-phenyl)-furan-2(3H)-ones (4a-p) have been synthesized and evaluated for their in vitro antimalarial activity against P. falciparum. The title compounds were synthesized by condensing 3-(substituted-benzoyl)propionic acids (3a-d) with substituted 2-chloroquinoline-3-carbaldehydes (2a-d) following modified Perkin's reaction. Compounds 3-[2-chloro-6-methylquinolin-3-yl)methylene]-5-(2,4-dimethyl-phenyl)-furan-2(3H)-one (4n) and 3-[2-chloro-6-methoxyquinolin-3-yl)methylene]-5-(2,4-dimethyl-phenyl)-furan-2(3H)-one (4p) showed promising antimalarial activity with MIC of 10 microg/mL.
一系列取代的3-[(取代-2-氯喹啉-3-基)亚甲基]-5-(取代苯基)-呋喃-2(3H)-酮(4a-p)已被合成,并对其针对恶性疟原虫的体外抗疟活性进行了评估。标题化合物是通过按照改进的珀金反应,将3-(取代苯甲酰基)丙酸(3a-d)与取代的2-氯喹啉-3-甲醛(2a-d)缩合而合成的。化合物3-[2-氯-6-甲基喹啉-3-基)亚甲基]-5-(2,4-二甲基苯基)-呋喃-2(3H)-酮(4n)和3-[2-氯-6-甲氧基喹啉-3-基)亚甲基]-5-(2,4-二甲基苯基)-呋喃-2(3H)-酮(4p)显示出有前景的抗疟活性,最低抑菌浓度为10微克/毫升。